Literature DB >> 26111426

Lipocalin-2 in the Inflammatory Activation of Brain Astrocytes.

Shinrye Lee, Mithilesh Kumar Jha, Kyoungho Suk.   

Abstract

Lipocalin-2 (LCN2), a secretory protein, regulates diverse cellular processes such as cell death/survival, cell migration/invasion, cell differentiation, iron delivery, inflammation, insulin resistance, and tissue regeneration. Recently, we reported that LCN2 is secreted by brain astrocytes under inflammatory conditions and that it promotes apoptosis, morphological changes, and migration in astrocytes both in vitro and in vivo. Activated astrocytes release LCN2 not only to induce the morphological transformation associated with reactive astrocytosis, but also to promote their own death. Under inflammatory conditions, activated astrocytes also show functional dichotomy similar to the M1/M2 phenotypes of microglia and macrophages. LCN2 is thought to be a chemokine inducer and an autocrine promoter of the classical proinflammatory activation of astrocytes. This article summarizes the current knowledge regarding the role of astrocyte-derived LCN2 as a proinflammatory mediator in the central nervous system and discusses LCN2’s role in neuroinflammatory disorders.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26111426     DOI: 10.1615/critrevimmunol.2015012127

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  23 in total

1.  Lipocalin 2 as a Putative Modulator of Local Inflammatory Processes in the Spinal Cord and Component of Organ Cross talk After Spinal Cord Injury.

Authors:  Victoria Behrens; Clara Voelz; Nina Müller; Weiyi Zhao; Natalie Gasterich; Tim Clarner; Cordian Beyer; Adib Zendedel
Journal:  Mol Neurobiol       Date:  2021-08-21       Impact factor: 5.590

2.  Lipocalin-2-Mediated Insufficient Oligodendrocyte Progenitor Cell Remyelination for White Matter Injury After Subarachnoid Hemorrhage via SCL22A17 Receptor/Early Growth Response Protein 1 Signaling.

Authors:  Qiang Li; Xufang Ru; Yang Yang; Hengli Zhao; Jie Qu; Weixiang Chen; Pengyu Pan; Huaizhen Ruan; Chaojun Li; Yujie Chen; Hua Feng
Journal:  Neurosci Bull       Date:  2022-07-07       Impact factor: 5.271

Review 3.  Lipocalin-2: a novel link between the injured kidney and the bone.

Authors:  Guillaume Courbon; Valentin David
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-07-01       Impact factor: 3.416

4.  Natural product HTP screening for attenuation of cytokine-induced neutrophil chemo attractants (CINCs) and NO2- in LPS/IFNγ activated glioma cells.

Authors:  Elizabeth A Mazzio; David Bauer; Patricia Mendonca; Equar Taka; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2016-12-01       Impact factor: 3.478

5.  Potential role of microRNA-7 in the anti-neuroinflammation effects of nicorandil in astrocytes induced by oxygen-glucose deprivation.

Authors:  Yin-Feng Dong; Zheng-Zhen Chen; Zhan Zhao; Dan-Dan Yang; Hui Yan; Juan Ji; Xiu-Lan Sun
Journal:  J Neuroinflammation       Date:  2016-03-09       Impact factor: 8.322

Review 6.  New Progress on the Role of Glia in Iron Metabolism and Iron-Induced Degeneration of Dopamine Neurons in Parkinson's Disease.

Authors:  Huamin Xu; Youcui Wang; Ning Song; Jun Wang; Hong Jiang; Junxia Xie
Journal:  Front Mol Neurosci       Date:  2018-01-19       Impact factor: 5.639

7.  RNA Nanotherapeutics for the Amelioration of Astroglial Reactivity.

Authors:  Jayden A Smith; Alice Braga; Jeroen Verheyen; Silvia Basilico; Sara Bandiera; Clara Alfaro-Cervello; Luca Peruzzotti-Jametti; Dan Shu; Farzin Haque; Peixuan Guo; Stefano Pluchino
Journal:  Mol Ther Nucleic Acids       Date:  2017-11-24       Impact factor: 8.886

8.  Translation in astrocyte distal processes sets molecular heterogeneity at the gliovascular interface.

Authors:  Anne-Cécile Boulay; Bruno Saubaméa; Nicolas Adam; Stéphanie Chasseigneaux; Noémie Mazaré; Alice Gilbert; Mathieu Bahin; Leïla Bastianelli; Corinne Blugeon; Sandrine Perrin; Juliette Pouch; Bertrand Ducos; Stéphane Le Crom; Auguste Genovesio; Fabrice Chrétien; Xavier Declèves; Jean-Louis Laplanche; Martine Cohen-Salmon
Journal:  Cell Discov       Date:  2017-03-28       Impact factor: 10.849

Review 9.  Molecular Effects of FDA-Approved Multiple Sclerosis Drugs on Glial Cells and Neurons of the Central Nervous System.

Authors:  Kim M A De Kleijn; Gerard J M Martens
Journal:  Int J Mol Sci       Date:  2020-06-13       Impact factor: 5.923

Review 10.  Oxidative Stress and Neuroinflammation Potentiate Each Other to Promote Progression of Dopamine Neurodegeneration.

Authors:  Jingyi He; Guofu Zhu; Guoqing Wang; Feng Zhang
Journal:  Oxid Med Cell Longev       Date:  2020-07-03       Impact factor: 7.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.